Target intelligence / Profile preview

MicroRNA 6790 (MIR6790)

Target
MIR6790
Molecular classification
Other (non-coding RNA; microRNA family)
01

Overview

MicroRNA 6790 (MIR6790, hsa-mir-6790) is classified as a microRNA, which are small, non-coding RNA molecules (typically 21–23 nucleotides) involved in post-transcriptional regulation of gene expression by binding to target messenger RNAs (mRNAs) and inhibiting their translation or promoting their degradation[1]. MicroRNAs are crucial regulators in many cellular processes, including differentiation, proliferation, and apoptosis[1][2]. However, there is currently no specific, functionally validated information on the role, targets, or disease links of MIR6790 in humans in major scientific literature or databases. It is possible that MIR6790 has been predicted computationally or annotated in sequence databases (e.g., miRBase), but its biological relevance, target genes, and involvement in disease remain undefined in peer-reviewed research to date.

Other names
hsa-mir-6790microRNA mir-6790MIR6790
02

Mechanism of action

null (no drugs known to target MIR6790; mechanisms of RNA interference or miRNA-mRNA binding apply generally to microRNAs)

03

Biological functions

Regulation of gene expressionpost-transcriptional gene silencingRNA interferencecell differentiationother general microRNA functions
04

Disease associations

Unknown/Other (no direct evidence for disease association or specific biological/pathological roles for MIR6790 in current literature or databases; general microRNA functions may loosely implicate it in cancer, inflammation, etc., but there are no specific studies or disease relationships established for MIR6790 itself)

Beyond the preview

Go deeper on MicroRNA 6790 (MIR6790).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 6790 (MIR6790).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call